Skip to main content
. 2016 Jun 20;10(6):e0004773. doi: 10.1371/journal.pntd.0004773

Fig 2. Seroprovalence of anti-CHIKV antibodies by neighborhood, District II of Managua, March–June 2015.

Fig 2

The seroprevalence for each neighborhood was calculated using participants from both the pediatric (2–14 years) and ≥15 year-old study populations. Seroprevalence levels were divided into four groups and color-coded, as shown in the legend key.